Morgan Stanley
INM icon

Morgan Stanley’s InMed Pharmaceuticals INM Stock Holding History

Morgan Stanley’s Portfolio INM Stock Details INM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7
Closed -$471 – 7857
2022
Q3 		$1K Buy
+7
New +$1.29K ﹤0.01% 7568
2021
Q3 		– Sell
-2
Closed -$2.38K – 7973
2021
Q2 		$2K Sell
2
-23
-92% -$35.6K ﹤0.01% 7525
2021
Q1 		$41K Buy
25
+11
+79% +$23.6K ﹤0.01% 6436
2020
Q4 		$23K Buy
+14
New +$22.7K ﹤0.01% 6392

Other funds holding INM

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AWM
AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
TWA
TCI Wealth Advisors Tucson, Arizona $1.88B AUM 21.09% 1-Year Est. Return